Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban with Diosmin for Acute DVT
NCT03413618Phase 4Completed
- Sponsor
- Pirogov Russian National Research Medical University
- Start
- Dec 2017
- Primary completion
- Jul 2019
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of diosmin in deep vein thrombosis (DVT), sponsored by Pirogov Russian National Research Medical University. Started Dec 2017; status: completed.
02
Drugs
diosmin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT03413618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03413618.